| |
| |
|
| Insider
Information: |
Knowles Julius |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
232,727 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
232,727 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keros Therapeutics, Inc. |
KROS |
Director |
|
0 |
2022-01-05 |
232,727 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2022-01-05 |
4 |
AS |
$57.23 |
$234,991 |
I/I |
(4,034) |
232,727 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2022-01-04 |
4 |
AS |
$54.95 |
$1,154,667 |
I/I |
(20,062) |
234,319 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2022-01-03 |
4 |
AS |
$56.82 |
$1,366,458 |
I/I |
(23,555) |
242,238 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-12-02 |
4 |
AS |
$51.99 |
$1,357,381 |
I/I |
(25,338) |
251,536 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-12-01 |
4 |
AS |
$53.48 |
$1,219,994 |
I/I |
(22,313) |
261,538 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-11-03 |
4 |
AS |
$41.65 |
$669,780 |
I/I |
(15,967) |
270,346 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-11-02 |
4 |
AS |
$42.10 |
$334,149 |
I/I |
(7,881) |
276,649 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-11-01 |
4 |
AS |
$41.85 |
$1,003,201 |
I/I |
(23,803) |
279,760 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-20 |
4 |
AS |
$37.55 |
$156,095 |
I/I |
(4,082) |
289,156 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-19 |
4 |
AS |
$38.05 |
$172,346 |
I/I |
(4,516) |
290,767 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-18 |
4 |
AS |
$37.69 |
$519,711 |
I/I |
(13,786) |
292,550 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-15 |
4 |
AS |
$38.95 |
$321,052 |
I/I |
(8,198) |
297,992 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-14 |
4 |
AS |
$40.13 |
$175,890 |
I/I |
(4,383) |
301,228 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-05 |
4 |
AS |
$40.03 |
$104,759 |
I/I |
(2,617) |
302,958 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-04 |
4 |
AS |
$40.06 |
$150,065 |
I/I |
(3,746) |
303,991 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-01 |
4 |
AS |
$40.16 |
$253,932 |
I/I |
(6,323) |
305,470 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-09-27 |
4 |
AS |
$40.51 |
$3,924,003 |
I/I |
(95,302) |
307,966 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-07-02 |
4 |
AS |
$41.08 |
$984,565 |
I/I |
(23,818) |
345,585 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-07-01 |
4 |
AS |
$41.22 |
$983,787 |
I/I |
(23,834) |
354,987 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-07 |
4 |
AS |
$46.48 |
$638,451 |
I/I |
(12,796) |
364,395 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-04 |
4 |
AS |
$47.23 |
$314,162 |
I/I |
(6,619) |
369,446 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-03 |
4 |
AS |
$47.69 |
$378,730 |
I/I |
(7,895) |
372,059 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-02 |
4 |
AS |
$48.35 |
$562,138 |
I/I |
(11,529) |
375,175 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-01 |
4 |
AS |
$51.90 |
$462,686 |
I/I |
(8,812) |
379,726 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-05-04 |
4 |
AS |
$53.73 |
$152,857 |
I/I |
(2,835) |
383,205 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
